Literature DB >> 25205181

Survey of obstetrician-gynecologists in the United States about toxoplasmosis: 2012 update.

Stephanie M Davis1, Britta L Anderson, Jay Schulkin, Katherine Jones, Jodi Vanden Eng, Jeffrey L Jones.   

Abstract

PURPOSE: Toxoplasmosis, caused by the parasite Toxoplasma gondii, can have serious impacts on fetal development in the setting of acute maternal primary infection. The American College of Obstetricians and Gynecologists (ACOG) sought to determine current knowledge, practices, opinions, and educational preferences regarding T. gondii infection in pregnancy among ACOG members practicing prenatal care.
METHODS: ACOG sent a survey to 1,056 members chosen by stratified random sampling from membership lists, including 370 participants and 686 non-participants in the Collaborative Ambulatory Research Network (CARN). Mailings were sent up to four times to nonresponders.
RESULTS: Survey minimum response rates were 40.3% (CARN) and 19.7% (non-CARN); response rates adjusted for imputed non-eligibility were 59.7% (CARN) and 22.6% (non-CARN). Among providers, 80.2% had diagnosed no acute maternal T. gondii infections in the past 5 years, 12.7% correctly identified the screening role of the Toxoplasma avidity test, 42.6% performed serologic T. gondii screening for at least some asymptomatic pregnant women, and 62.1% of those who so did used appropriate approaches. Providers in the northeastern United States were 2.02 times more likely to routinely screen than those in the west (p = 0.025) and female providers were 1.48 times more likely than male providers (p = 0.047). The potential educational interventions considered useful by the most practitioners were updated ACOG guidelines on screening (81.4%) and management (71.7%) for acute T. gondii infection in pregnancy.
CONCLUSIONS: ACOG members would benefit from educational efforts targeted at risk factor counseling and screening approaches.

Entities:  

Mesh:

Year:  2014        PMID: 25205181      PMCID: PMC4720129          DOI: 10.1007/s00404-014-3450-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  34 in total

Review 1.  Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis.

Authors:  Rodolphe Thiébaut; Valériane Leroy; Ahmadou Alioum; Christine Binquet; Gwendoline Poizat; L Rachid Salmi; Luuk Gras; Roger Salamon; Ruth Gilbert; Geneviève Chêne
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-09-02       Impact factor: 2.435

2.  Toxoplasmosis during pregnancy and infancy. A new approach for Switzerland.

Authors:  K Boubaker; P A Raeber; B Vaudaux; H C Bucher; J G Garweg; I Hoesli; C Kind; P Hohlfeld
Journal:  Swiss Med Wkly       Date:  2008-12-13       Impact factor: 2.193

3.  Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France.

Authors:  C Cornu; A Bissery; C Malbos; R Garwig; C Cocherel; R Ecochard; F Peyron; M Wallon
Journal:  Euro Surveill       Date:  2009-03-05

4.  False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test.

Authors:  O Liesenfeld; C Press; J G Montoya; R Gill; J L Isaac-Renton; K Hedman; J S Remington
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 5.  Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological consequences for women who undergo screening.

Authors:  Babak Khoshnood; Catherine De Vigan; François Goffinet; Valériane Leroy
Journal:  Prenat Diagn       Date:  2007-05       Impact factor: 3.050

6.  Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group.

Authors:  M Wilson; J S Remington; C Clavet; G Varney; C Press; D Ware
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.

Authors:  W Foulon; I Villena; B Stray-Pedersen; A Decoster; M Lappalainen; J M Pinon; P A Jenum; K Hedman; A Naessens
Journal:  Am J Obstet Gynecol       Date:  1999-02       Impact factor: 8.661

8.  Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade.

Authors:  Jeffrey L Jones; Deanna Kruszon-Moran; Kolby Sanders-Lewis; Marianna Wilson
Journal:  Am J Trop Med Hyg       Date:  2007-09       Impact factor: 2.345

Review 9.  Management of Toxoplasma gondii infection during pregnancy.

Authors:  Jose G Montoya; Jack S Remington
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

10.  Serological survey of Toxoplasma gondii infection in domestic cats from northeastern Portugal.

Authors:  Ana Patrícia Lopes; Luís Cardoso; Manuela Rodrigues
Journal:  Vet Parasitol       Date:  2008-05-10       Impact factor: 2.738

View more
  5 in total

1.  Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States.

Authors:  Reshika Dhakal; Kiran Gajurel; Christelle Pomares; Jeanne Talucod; Cynthia J Press; Jose G Montoya
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

2.  Toxoplasmosis - Awareness and knowledge among medical doctors in Nigeria.

Authors:  Akinwale Michael Efunshile; Charles John Elikwu; Pikka Jokelainen
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

3.  Knowledge and Practices of Toxoplasmosis among Clinical Laboratory Professionals: A Cross-Sectional Study in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Luis Francisco Sánchez-Anguiano; Luis Omar Berumen-Segovia; Jesús Hernández-Tinoco; Yazmin Del Rosario Rico-Almochantaf; Alfredo Cisneros-Camacho; Jorge Arturo Cisneros-Martínez
Journal:  Int J Environ Res Public Health       Date:  2017-11-18       Impact factor: 3.390

4.  The first report of the evaluation of the knowledge regarding toxoplasmosis among health professionals in public health centers in Rabat, Morocco.

Authors:  Majda Laboudi; Sanaa Ait Hamou; Imane Mansour; Ilham Hilmi; Abderrahim Sadak
Journal:  Trop Med Health       Date:  2020-04-09

Review 5.  Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings.

Authors:  Branko Bobić; Isabelle Villena; Eileen Stillwaggon
Journal:  Food Waterborne Parasitol       Date:  2019-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.